Pharmaceutical Industry Information Portal

HomeManufacturers News

Manufacturers News

Global Biopharmaceutical Industry is on track to produce at least 10 billion doses of COVID-19 vaccine by end 2021

Biopharmaceutical industry welcomes COVID-19 vaccine-sharing pledges but warn challenges remain to urgently address vaccine inequity

Leading infectious disease experts in Russia recognized the efficacy of Avifavir

Professor A.V. Devyatkin noted the efficacy of Avifavir® in the combined treatment of patients with COVID-19.

Creating a site for heart disease drug production on the basis of Pharmasyntez-Tyumen

The plant is actively expanding its portfolio and introducing new production facilities. Bilateral cooperation between government and business will continue in the future.

The plant of Nanolek is about to launch production of the third Covivac vaccine

Nanolek uses a traditional technology to produce this vaccine containing an inactivated virus that triggers a potent immune response.

Tatyana Golikova: Russia should minimize imports of medicines

Russia should minimize its dependence on imports of ready-made medicines and pharmaceutical substances, Russian Deputy Prime Minister Tatyana Golikova said on Thursday. /TASS/ "In 2020,...

Egyptian company SOLYPHAR will build a pharmaceutical company in Uzbekistan

It is envisaged to implement the project in three stages from 2021 to 2024, the amount of investment from the company "SOLYPHAR" will be more than 20 million US dollars, in accordance to the international GMP standards.
spot_img

Expert Articles

spot_img